Rat models of type 1 diabetes: genetics, environment, and autoimmunity

ILAR Journal
John P MordesDale L Greiner

Abstract

For many years, the vast amount of data gathered from analysis of nonobese diabetic (NOD) and congenic NOD mice has eclipsed interest in the rat for the study of type 1 diabetes. The study of rat models has continued, however, and recently there has been a reanimation of interest for several reasons. First, genetic analysis of the rat has accelerated. Ian4L1, cblb, and Iddm4 are now known to play major roles in rat autoimmunity. Second, rats are amenable to study the interactions of genetics and environment that may be critical for disease expression in humans. Environmental perturbants that predictably enhance the expression of rat autoimmune diabetes include viral infection, toll-like receptor ligation, and depletion of regulatory T cell populations. Finally, data generated in the rat have correctly predicted the outcome of several human diabetes prevention trials, notably the failure of nicotinamide and low dose parenteral and oral insulin therapies.

References

Sep 1, 1992·Nature Genetics·H J JacobE S Lander
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z J ZhangH L Weiner
Dec 1, 1990·Journal of Autoimmunity·M W SadelainA Rabinovitch
Oct 1, 1990·Annals of the Rheumatic Diseases·R A Johnston, I G Kelly
Jan 1, 1989·Autoimmunity·E S HandlerA A Rossini
Jan 1, 1989·Autoimmunity·L HermitteP Vague
Jan 1, 1986·Diabetic Medicine : a Journal of the British Diabetic Association·R E Ferner, K G Alberti
Jan 1, 1988·The Journal of Experimental Medicine·H M GeorgiouD Bellgrau
Mar 1, 1988·The Journal of Clinical Investigation·T DyrbergM B Oldstone
Aug 1, 1987·The Journal of Experimental Medicine·D L GreinerA A Rossini
Apr 1, 1986·Diabetologia·Y MoriM Nishimura
Jan 1, 1983·Lancet·A LaupacisP Thibert
Jul 1, 1983·Metabolism: Clinical and Experimental·R JacksonG S Eisenbarth
Oct 1, 1981·Diabetes·R JacksonG S Eisenbarth
Jul 1, 1995·Clinical and Experimental Immunology·C DavenportI Todd
Oct 28, 1994·Journal of Molecular Biology·F HaagH G Thiele
Nov 30, 1993·Annals of the New York Academy of Sciences·R B ElliottM A McGregor

❮ Previous
Next ❯

Citations

Jun 17, 2006·Pharmaceutical Research·Patrick Couvreur, Christine Vauthier
Jul 2, 2004·ILAR Journal·Stephen W Barthold
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Ken T CoppietersMatthias von Herrath
Jul 20, 2006·Annual Review of Nutrition·David E LefebvreFraser W Scott
Apr 9, 2009·Physiological Genomics·J M FullerA E Kwitek
Oct 23, 2013·PloS One·Chaoxing YangRita Bortell
May 12, 2007·The Review of Diabetic Studies : RDS·Erik BirosAlan G Baxter
Feb 14, 2009·International Journal of Biological Sciences·Hongxia ZhouXu Gang Xia
May 19, 2010·Biomarkers in Medicine·Neeraj KumarNarinder Mehra
Mar 30, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Aaron W Michels
Jan 14, 2011·Annual Review of Medicine·Giovanni MussoMaurizio Cassader
Jan 11, 2007·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Fúlvia de Barros ManchadoMaria Alice Rostom de Mello
Aug 14, 2010·Journal of Pediatric Gastroenterology and Nutrition·Nan LiJosef Neu
Dec 4, 2009·International Reviews of Immunology·Brigitte SonierFraser W Scott
May 20, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Susanne M CabreraMartin J Hessner
Sep 28, 2013·Canadian Journal of Diabetes·Satarupa AcharjeeAnroop B Nair
Jan 15, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Naoko HaraDanny Zipris
Apr 24, 2012·Journal of Diabetes and Its Complications·Ishwarlal JialalSridevi Devaraj
Oct 4, 2015·Biochemical Pharmacology·Aileen King, James Bowe
Jun 15, 2010·Immunobiology·Amaya OyarzúnFrancisco Pérez-Bravo
Jan 17, 2009·Diabetes Research and Clinical Practice·Scherezade MominFrancisco Perez-Bravo
Nov 27, 2007·European Journal of Pharmacology·Yagna P R JarajapuHarm J Knot
Feb 23, 2012·British Journal of Pharmacology·Aileen J F King
Nov 10, 2011·Diabetes/metabolism Research and Reviews·Danny Zipris
Feb 19, 2011·Journal of Biomedicine & Biotechnology·Geanina OnutaJan-Luuk Hillebrands

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.